OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 150 filers reported holding OCULAR THERAPEUTIX INC in Q2 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $112,431 | -27.0% | 35,806 | +20.0% | 0.00% | – |
| Q2 2023 | $153,984 | -42.8% | 29,842 | -41.6% | 0.00% | – |
| Q1 2023 | $269,166 | +174.5% | 51,075 | +46.4% | 0.00% | – |
| Q4 2022 | $98,061 | -31.4% | 34,897 | +1.5% | 0.00% | – |
| Q3 2022 | $143,000 | -10.1% | 34,382 | -13.0% | 0.00% | – |
| Q2 2022 | $159,000 | -28.4% | 39,528 | -11.7% | 0.00% | – |
| Q1 2022 | $222,000 | -35.5% | 44,783 | -9.5% | 0.00% | – |
| Q4 2021 | $344,000 | -33.1% | 49,485 | -3.8% | 0.00% | – |
| Q3 2021 | $514,000 | -35.9% | 51,460 | -9.0% | 0.00% | – |
| Q2 2021 | $802,000 | -7.6% | 56,527 | +6.8% | 0.00% | – |
| Q1 2021 | $868,000 | -31.6% | 52,922 | -13.7% | 0.00% | -100.0% |
| Q4 2020 | $1,269,000 | +3.3% | 61,297 | -62.1% | 0.00% | 0.0% |
| Q3 2020 | $1,229,000 | +38.1% | 161,533 | +51.3% | 0.00% | 0.0% |
| Q2 2020 | $890,000 | +1119.2% | 106,773 | +629.1% | 0.00% | – |
| Q1 2020 | $73,000 | +23.7% | 14,645 | -4.6% | 0.00% | – |
| Q4 2019 | $59,000 | +73.5% | 15,348 | +31.2% | 0.00% | – |
| Q3 2019 | $34,000 | -71.7% | 11,696 | -57.9% | 0.00% | – |
| Q2 2019 | $120,000 | -28.6% | 27,795 | -35.4% | 0.00% | – |
| Q1 2019 | $168,000 | +5.7% | 43,038 | +6.6% | 0.00% | – |
| Q4 2018 | $159,000 | -83.8% | 40,361 | -71.8% | 0.00% | – |
| Q3 2018 | $983,000 | +27.5% | 143,221 | +25.1% | 0.00% | – |
| Q2 2018 | $771,000 | +217.3% | 114,514 | +203.5% | 0.00% | – |
| Q1 2018 | $243,000 | +10.0% | 37,728 | -24.6% | 0.00% | – |
| Q4 2017 | $221,000 | +81.1% | 50,065 | +148.7% | 0.00% | – |
| Q3 2017 | $122,000 | -89.3% | 20,127 | -83.6% | 0.00% | -100.0% |
| Q2 2017 | $1,138,000 | -8.2% | 122,989 | -8.0% | 0.00% | 0.0% |
| Q1 2017 | $1,239,000 | +21.7% | 133,677 | +9.7% | 0.00% | 0.0% |
| Q4 2016 | $1,018,000 | +46.9% | 121,892 | +20.7% | 0.00% | – |
| Q3 2016 | $693,000 | +9.3% | 100,961 | -21.2% | 0.00% | – |
| Q2 2016 | $634,000 | -34.0% | 128,187 | +28.7% | 0.00% | -100.0% |
| Q1 2016 | $961,000 | +2.5% | 99,629 | -0.7% | 0.00% | 0.0% |
| Q4 2015 | $938,000 | -33.6% | 100,361 | -0.1% | 0.00% | 0.0% |
| Q3 2015 | $1,412,000 | -32.5% | 100,496 | +1.0% | 0.00% | 0.0% |
| Q2 2015 | $2,092,000 | -49.4% | 99,535 | +1.0% | 0.00% | -66.7% |
| Q1 2015 | $4,137,000 | +82.6% | 98,567 | +2.3% | 0.00% | +200.0% |
| Q4 2014 | $2,266,000 | +51.4% | 96,358 | -3.6% | 0.00% | 0.0% |
| Q3 2014 | $1,497,000 | – | 100,002 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,932,607 | $40,643,000 | 15.56% |
| Lamond Capital Partners LLC | 711,533 | $14,964,000 | 15.19% |
| Polaris Venture Management Co. V, L.L.C. | 1,230,009 | $25,867,000 | 11.54% |
| NOTTINGHAM ADVISORS, INC. | 171,985 | $3,617,000 | 0.60% |
| Portolan Capital Management | 122,518 | $2,577,000 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 160,000 | $3,365,000 | 0.33% |
| Rotella Capital Management, Inc. | 18,461 | $388,000 | 0.32% |
| Monashee Investment Management LLC | 28,834 | $606,000 | 0.29% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 335,498 | $7,056,000 | 0.24% |
| BAILARD, INC. | 55,000 | $1,157,000 | 0.18% |